3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Burkitt Lymphoma
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Hodgkin Disease
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
Vincristine
1
Vemurafenib
1
Sorafenib
1
Pharmacogenomic Variants
1
Oxaliplatin
1
Mesna
1
LY3023414
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Peripheral Blood Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.